Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 47Lung Neoplasms 29Neoplasms 27Colorectal Neoplasms 21Prostatic Neoplasms 16Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Fatigue 9Anxiety Disorders 8Neoplasm Metastasis 7Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Papillomavirus Infections 6Melanoma 6Ovarian Neoplasms 5Multiple Myeloma 5Head and Neck Neoplasms 5Gastrointestinal Neoplasms 5Depression 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Skin Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3

Interventions

relacorilant 5Pioglitazone 4Metformin 4Sitagliptin Phosphate 3Resistance Training 3Dipeptidyl-Peptidase IV Inhibitors 3saxagliptin 2Vildagliptin 2Sulfonylurea Compounds 2Rosiglitazone 2Nutritional Status 2Blood Specimen Collection 2voglibose 1somapacitan 1semaglutide 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1mazdutide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1dapagliflozin 1alogliptin 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus, Type 2 × Educational Status × Clear all
NCT04938869 2023-02-24

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡